Sarcoma  >>  vincristine  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

7 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
vincristine / Generic mfg.
NCT00618813: Two Regimens of Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Localized Ewing Sarcoma Family of Tumors

Completed
N/A
35
US
radiation therapy, irradiation, radiotherapy, therapy, radiation, therapeutic conventional surgery, etoposide, EPEG, VP-16, VP-16-213, ifosfamide, Cyfos, Holoxan, IFF, IFX, IPP, doxorubicin hydrochloride, ADM, ADR, Adria, Adriamycin PFS, Adriamycin RDF, cyclophosphamide, CPM, CTX, Cytoxan, Endoxan, Endoxana, vincristine sulfate, leurocristine sulfate, VCR, Vincasar PFS, topotecan hydrochloride, hycamptamine, Hycamtin, SKF S-104864-A, TOPO, filgrastim, G-CSF, Neupogen
Children's Oncology Group, National Cancer Institute (NCI)
Ewing Sarcoma of Bone, Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
03/10
 
NCT00410488: Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI)

Completed
N/A
51
US
Palonosetron - Single Dose, Aloxi, Palonosetron - Triple Dose, Adriamycin, Doxorubicin, Doxorubicin Hydrochloride, Adriamycin PFS, Adrimaycin RDF, Rubex, Ifosfamide chemotherapy (AI), Ifex, Zinecard, Dexrazoxane, Mesna, mesnex, Vincristine, Dexamethasone, Decadron, Dexamethasone acetate
M.D. Anderson Cancer Center, Eisai Inc.
Sarcoma, Nausea, Vomiting
06/11
06/11
NCT01490060: Fosaprepitant in Patients Receiving Ifosfamide-based Regimen

Completed
N/A
47
US
Fosaprepitant, Fosaprepitant Dimeglumine, Dexamethasone, Dexamethasone acetate, Decadron, 5HT3 receptor antagonist, Ifosfamide-based chemotherapy (AI), Doxorubicin, Rubex, Adriamycin, Adriamycin RDF, Adriamycin PFS, Doxorubicin Hydrochloride, Mesna, Mesnex, Ifosfamide, Ifex, Vincristine
M.D. Anderson Cancer Center, Merck Sharp & Dohme LLC
Sarcoma, Chemotherapy-induced Nausea and Vomiting, Effects of Chemotherapy, Adverse Effects of Medical Drugs
03/16
03/16
NCT00674193: Evaluating Dactinomycin and Vincristine in Young Patients With Cancer

Completed
N/A
158
US, Canada, RoW
pharmacological study, pharmacological studies, laboratory biomarker analysis
Children's Oncology Group, National Cancer Institute (NCI)
Childhood Acute Lymphoblastic Leukemia, Childhood Rhabdomyosarcoma, Childhood Soft Tissue Sarcoma, Ewing Sarcoma, Ewing Sarcoma of Bone, Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor (PNET), Unspecified Childhood Solid Tumor, Protocol Specific, Wilms Tumor and Other Childhood Kidney Tumors
06/16
 
NCT03596918: Evaluating Quality of Life in Patients With AIDS-Associated Kaposi Sarcoma Treated With Bleomycin and Vincristine

Completed
N/A
10
RoW
Bleomycin Sulfate, Blanoxan, BleMomycine, Blenoxane, Bleo-cell, Bleo-S, Bleocin, Bleolem, Bleomycin Sulfas, Bleomycin Sulphate, Blexane, Oil Bleo, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration, Vincristine Sulfate, Kyocristine, Leurocristine sulfate, Leurocristine, sulfate, Oncovin, Vincasar, Vincosid, Vincrex, Vincristine, sulfate
AIDS Malignancy Consortium, National Cancer Institute (NCI), The Emmes Company, LLC, University of Arkansas, University of California, Los Angeles
AIDS-Related Kaposi Sarcoma, Human Immunodeficiency Virus 1 Positive
06/20
06/20
NCT06451302: Risk Stratification Oriented Treatment of Pediatric Ewing Sarcoma: a Prospective Multicenter Cohort Study

Active, not recruiting
N/A
100
RoW
cyclophosphamide, adriamycin, vincristine，Ifosfamide，etoposide, vinorelbine
Yizhuo Zhang
Ewing Sarcoma, Risk Stratification
05/27
12/27
NCT05656222: Irinotecan and Anlotinib for Epithelioid Sarcoma

Withdrawn
N/A
10
RoW
VIA combination treatment
Peking University People's Hospital
Objective Response, Overall Survival
10/24
12/24

Download Options